サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606459

インスリン注射補助器具市場：製品別、最終用途別、国別、地域別 - 2024～2032年の産業分析、市場規模、市場シェア、予測

Insulin Injection Aids Market, By Product, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
インスリン注射補助器具市場：製品別、最終用途別、国別、地域別 - 2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートのハイライト

インスリン注射補助器具の市場規模は2023年に2億3,980万米ドルとなり、2024年から2032年にかけてCAGR 7.40%で拡大します。

インスリン注射補助器具市場 - 市場力学

世界の糖尿病有病率の増加が市場需要を押し上げる

糖尿病の世界の有病率は著しく増加しており、国際糖尿病連合は、2021年には約5億3,700万人の成人が糖尿病を患っていると報告しています。このような患者数の増加が、インスリン注射補助器具市場の高い需要を生み出しています。しかし、先進的なインスリン注入補助器具の初期費用は、患者によっては高額になる可能性があり、また新しい医療器具の承認プロセスには時間がかかり複雑であるため、業界の成長が制限される可能性があります。逆に、糖尿病管理に対する意識の高まりは、市場拡大の機会を生み出しています。さらに、スマートペンやインスリンポンプなどの先進的なインスリン送達デバイスの開発が、糖尿病管理に変革をもたらしつつあります。

インスリン注射補助器具市場 - 主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約7.40％のCAGRで毎年成長すると推定されます。

製品セグメンテーションに基づくと、シリンジエイドは2023年に最大市場シェアを示すと予測されています。

最終用途セグメンテーションに基づくと、2023年には病院が主要セグメントです。

地域別では、北米のインスリン注射補助器具が2023年に主要な収益源となりました。

インスリン注射補助器具市場 - セグメンテーション分析：

インスリン注射補助器具の世界市場は、製品、最終用途、地域に基づいてセグメント化されます。

製品は、注射補助器具、インスリンバイアル補助器具、子ども用補助器具、インジェクター、その他の5つに分類されます。市場を独占しているのはシリンジ補助器具の分野です。これは主に、手頃な価格と、注射針の誘導や人間工学に基づいたデザインなどの安全機能により、注射時の利便性と快適性が向上しているためです。

市場は最終用途に基づき、専門クリニック、病院、在宅ケア環境、その他の4つのカテゴリーに分類されます。予測期間中、CAGRが最も高く成長すると予測されるのは病院分野です。これは、熟練したヘルスケア専門家が利用可能であること、政府および民間部門からの投資が増加していることが一因です。このため、複雑な糖尿病患者の治療には効率的なインスリン送達システムが必要であることが強調されています。

インスリン注射補助器具市場 - 地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

インスリン注射補助器具市場 - 競合情勢：

糖尿病有病率の上昇がインスリン注射補助器具市場の技術革新を促進しています。企業は、人間工学に基づいた設計や統合された安全機構などの機能を通じて、ユーザーエクスペリエンスを向上させる先進的な送達デバイスの開発に注力しています。戦略的提携や協力関係は、市場へのリーチを拡大し、技術統合を向上させる上で極めて重要になってきています。さらに、メーカー各社はより効果的でユーザーフレンドリーなデバイスを開発するための研究開発に投資し、規制基準への準拠を確実なものにしています。競争が激化する中、各社は手頃な価格とアクセシビリティを優先し、市場の長期的成長と持続可能性を確保しつつ、多様な患者集団のニーズを満たすことを目指しています。

目次

第1章 インスリン注射補助器具市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 インスリン注射補助器具の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 インスリン注射補助器具産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 インスリン注射補助器具市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 インスリン注射補助器具市場情勢

  • インスリン注射補助器具市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 インスリン注射補助器具市場：製品別

  • 概要
    • 製品別セグメントシェア分析
    • 注射器補助器具
    • インスリンバイアル補助器具
    • 子ども用補助器具
    • インジェクター
    • その他

第8章 インスリン注射補助器具市場：最終用途別

  • 概要
    • セグメントシェア分析、最終用途別
    • 専門クリニック
    • 病院
    • ホームケア設定
    • その他

第9章 インスリン注射補助器具市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - インスリン注射補助器具業界

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • Medtronic Plc
    • Becton, Dickinson and Co.
    • Convatec Inc.
    • AmbiMedInc.
    • TickleTec Ltd.
    • Medicool
    • Pain Care Labs
    • BIONIX LLC
    • Apothecary Products
    • Prodigy Diabetes Care, LLC
    • Abbott
    • Others

第11章 アナリストの全方位展望

目次
Product Code: ANV4174

REPORT HIGHLIGHT

Insulin injection aids market size was valued at USD 239.80 Million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

Insulin injection aids are medical devices designed to facilitate the administration of insulin for diabetes management. These aids enhance the delivery process by providing features, such as ergonomic designs, needle guidance, and integrated safety mechanisms to prevent needle stick injuries. Common types include insulin pens, syringes, and insulin pumps, which offer various methods of insulin delivery. By improving accuracy, convenience, and comfort, insulin injection aids empower patients to manage their diabetes more effectively.

Insulin Injection Aids Market- Market Dynamics

Increasing prevalence of diabetes worldwide to boost market demand

The global prevalence of diabetes is increasing significantly, with the International Diabetes Federation reporting that approximately 537 million adults are living with diabetes in 2021. This growing patient population creates a higher demand for insulin injection aids market. However, the initial cost of advanced insulin delivery devices can be prohibitive for some patients and the approval process for new medical devices can be lengthy and complex, which may restrict the industry growth. On the contrary, increasing awareness about diabetes management is creating opportunities for market expansion. Furthermore, the development of advanced insulin delivery devices, such as smart pens and insulin pumps, is transforming diabetes management.

Insulin Injection Aids Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on product segmentation, syringe aids is predicted to show maximum market share in the year 2023

Based on end-use segmentation, hospitals were the leading segment in 2023

On the basis of region, the North America insulin injection aids North America was the leading revenue generator in 2023

Insulin Injection Aids Market- Segmentation Analysis:

The Global Insulin Injection Aids Market is segmented on the basis of Product, End-use, and Region.

The market is divided into five categories based on product: syringe aids, insulin vial aids, aids for aids, injectors, and others. The syringe aids sector dominates the market. This is mainly due to their affordability and safety features, such as needle guidance and ergonomic designs, enhancing convenience and comfort during injections.

The market is divided into four categories based on end-use: specialty clinics, hospitals, home care settings, and others. The hospitals sector is predicted to grow at the highest CAGR during the forecast period. This is partly due to the availability of skilled healthcare professionals and increased investments from both government and private sectors. This emphasizes the need for efficient insulin delivery systems in treating complicated diabetes cases.

Insulin Injection Aids Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Insulin Injection Aids Market- Competitive Landscape:

The rising prevalence of diabetes is driving innovation in the insulin injection aids market. Companies are focusing on developing advanced delivery devices that enhance user experience through features like ergonomic designs and integrated safety mechanisms. Strategic partnerships and collaborations are becoming crucial for expanding market reach and improving technology integration. Furthermore, manufacturers are investing in research and development to create more effective and user-friendly devices, ensuring compliance with regulatory standards. As competition intensifies, companies are also prioritizing affordability and accessibility, aiming to meet the needs of diverse patient populations while ensuring long-term growth and sustainability in the market.

Recent Developments:

In August 2024, Abbott partnered with Medtronic to create an integrated continuous glucose monitoring (CGM) system using Abbott's advanced FreeStyle Libre technology. This collaboration will connect with Medtronic's automated insulin delivery systems, allowing automatic insulin adjustments to maintain glucose levels, enhancing diabetes management for patients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INSULIN INJECTION AIDS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic Plc
  • Becton, Dickinson and Co.
  • Convatec Inc.
  • AmbiMedInc.
  • TickleTec Ltd.
  • Medicool
  • Pain Care Labs
  • BIONIX LLC
  • Apothecary Products
  • Prodigy Diabetes Care, LLC
  • Abbott
  • Others

GLOBAL INSULIN INJECTION AIDS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Syringe Aids
  • Insulin Vial Aids
  • Aids for Kids
  • Injectors
  • Others

GLOBAL INSULIN INJECTION AIDS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Hospitals
  • Home Care Settings
  • Others

GLOBAL INSULIN INJECTION AIDS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Insulin Injection Aids Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Insulin Injection Aids Market Snippet by Product
    • 2.1.2. Insulin Injection Aids Market Snippet by End-use
    • 2.1.3. Insulin Injection Aids Market Snippet by Country
    • 2.1.4. Insulin Injection Aids Market Snippet by Region
  • 2.2. Competitive Insights

3. Insulin Injection Aids Key Market Trends

  • 3.1. Insulin Injection Aids Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Insulin Injection Aids Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Insulin Injection Aids Market Opportunities
  • 3.4. Insulin Injection Aids Market Future Trends

4. Insulin Injection Aids Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Insulin Injection Aids Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Insulin Injection Aids Market Landscape

  • 6.1. Insulin Injection Aids Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Insulin Injection Aids Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Syringe Aids
    • 7.1.3. Insulin Vial aids
    • 7.1.4. Aids for Kids
    • 7.1.5. Injectors
    • 7.1.6. Others

8. Insulin Injection Aids Market - By End-use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 8.1.2. Specialty Clinics
    • 8.1.3. Hospitals
    • 8.1.4. Home Care Settings
    • 8.1.5. Others

9. Insulin Injection Aids Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Insulin Injection Aids Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Insulin Injection Aids Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Insulin Injection Aids Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Insulin Injection Aids Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Insulin Injection Aids Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Insulin Injection Aids Industry

  • 10.1. Competitive Dashboard
    • 10.1.1. Competitive Benchmarking
    • 10.1.2. Competitive Positioning
  • 10.2. Company Profiles
    • 10.2.1. Medtronic Plc
    • 10.2.2. Becton, Dickinson and Co.
    • 10.2.3. Convatec Inc.
    • 10.2.4. AmbiMedInc.
    • 10.2.5. TickleTec Ltd.
    • 10.2.6. Medicool
    • 10.2.7. Pain Care Labs
    • 10.2.8. BIONIX LLC
    • 10.2.9. Apothecary Products
    • 10.2.10. Prodigy Diabetes Care, LLC
    • 10.2.11. Abbott
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us